Vincent Lisowski

2.8k total citations · 1 hit paper
58 papers, 2.3k citations indexed

About

Vincent Lisowski is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Vincent Lisowski has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Organic Chemistry, 31 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Vincent Lisowski's work include Synthesis and pharmacology of benzodiazepine derivatives (12 papers), Chemical Synthesis and Analysis (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (8 papers). Vincent Lisowski is often cited by papers focused on Synthesis and pharmacology of benzodiazepine derivatives (12 papers), Chemical Synthesis and Analysis (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (8 papers). Vincent Lisowski collaborates with scholars based in France, New Zealand and South Korea. Vincent Lisowski's co-authors include Jean Martínez, Patrick Vlieghe, Sylvain Rault, Nicolas Masurier, Ludovic T. Maillard, Patrick Dallemagne, Christophe Rochais, Cyril Fersing, S. Rault and Jean‐François Hernandez and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Vincent Lisowski

56 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic therapeutic peptides: science and market

2009 1.2k citations Vincent Lisowski, Jean Martínez et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Vincent Lisowski	1.4k	907	359	251	220	58	2.3k
Luca Gentilucci	2.1k 1.6×	1.5k 1.6×	210 0.6×	237 0.9×	247 1.1×	146	3.3k
Judit Tulla‐Puche	1.7k 1.2×	1.2k 1.3×	307 0.9×	237 0.9×	153 0.7×	58	2.3k
Huy N. Hoang	1.7k 1.3×	701 0.8×	229 0.6×	237 0.9×	165 0.8×	79	2.2k
Gunnar Lindeberg	1.4k 1.0×	632 0.7×	237 0.7×	346 1.4×	352 1.6×	89	2.7k
Nicholas E. Shepherd	1.7k 1.2×	896 1.0×	198 0.6×	172 0.7×	176 0.8×	33	2.1k
John M. Nuss	1.3k 0.9×	847 0.9×	188 0.5×	145 0.6×	112 0.5×	30	1.9k
Patrick Vlieghe	1.1k 0.8×	296 0.3×	315 0.9×	184 0.7×	173 0.8×	13	1.5k
Marc Devocelle	1.3k 1.0×	448 0.5×	334 0.9×	320 1.3×	60 0.3×	83	2.4k
Michael K. Dunn	1.2k 0.9×	265 0.3×	262 0.7×	157 0.6×	153 0.7×	6	1.6k
Ziqing Qian	1.7k 1.2×	552 0.6×	282 0.8×	229 0.9×	235 1.1×	37	2.1k

Countries citing papers authored by Vincent Lisowski

Since Specialization

Citations

This map shows the geographic impact of Vincent Lisowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Lisowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Lisowski more than expected).

Fields of papers citing papers by Vincent Lisowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Lisowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Lisowski. The network helps show where Vincent Lisowski may publish in the future.

Co-authorship network of co-authors of Vincent Lisowski

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Lisowski. A scholar is included among the top collaborators of Vincent Lisowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Lisowski. Vincent Lisowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amanzougaghene, Nadia, Sébastien Hutter, Jean‐François Franetich, et al.. (2023). New antiplasmodial 4-amino-thieno[3,2-d]pyrimidines with improved intestinal permeability and microsomal stability. European Journal of Medicinal Chemistry. 249. 115115–115115. 6 indexed citations

Hutter, Sébastien, Jean‐François Franetich, Aurélie Malzert‐Fréon, et al.. (2023). Novel thienopyrimidones targeting hepatic and erythrocytic stages of Plasmodium parasites with increased microsomal stability. European Journal of Medicinal Chemistry. 261. 115873–115873. 2 indexed citations

Amanzougaghene, Nadia, Sébastien Hutter, Jean‐François Franetich, et al.. (2022). 4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives. Pharmaceuticals. 15(7). 820–820. 4 indexed citations

Hutter, Sébastien, Nadia Amanzougaghene, Jean‐François Franetich, et al.. (2022). Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy. European Journal of Medicinal Chemistry. 241. 114619–114619. 5 indexed citations

Fersing, Cyril, et al.. (2021). Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents. Pharmaceuticals. 15(1). 35–35. 35 indexed citations

Verdié, Pascal, Audrey Davis, Sophie Corvaisier, et al.. (2021). Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment. Pharmaceutics. 13(10). 1626–1626. 9 indexed citations

Fersing, Cyril, et al.. (2021). Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators. EJNMMI Radiopharmacy and Chemistry. 6(1). 2–2. 1 indexed citations

Fersing, Cyril, et al.. (2020). Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systems. Bioorganic & Medicinal Chemistry Letters. 30(22). 127527–127527. 7 indexed citations

Peyressatre, Marion, Juan A. González‐Vera, Morgan Pellerano, et al.. (2020). Identification of Quinazolinone Analogs Targeting CDK5 Kinase Activity and Glioblastoma Cell Proliferation. Frontiers in Chemistry. 8. 691–691. 13 indexed citations

10.

Bellet, Virginie, Audrey Gallud, Vincent Lisowski, et al.. (2016). Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells. European Journal of Medicinal Chemistry. 125. 1225–1234. 17 indexed citations

11.

Lisowski, Vincent, et al.. (2015). Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7. European Journal of Medicinal Chemistry. 93. 202–213. 18 indexed citations

12.

Gallud, Audrey, Ophélie Vaillant, Ludovic T. Maillard, et al.. (2014). Imidazopyridine-fused [1,3]-diazepinones: Synthesis and antiproliferative activity. European Journal of Medicinal Chemistry. 75. 382–390. 41 indexed citations

13.

Legrand, Baptiste, Cheng Deng, Lubomir Vezenkov, et al.. (2013). Helical Oligomers of Thiazole‐Based γ‐Amino Acids: Synthesis and Structural Studies. Angewandte Chemie International Edition. 52(23). 6006–6010. 59 indexed citations

14.

Peuchmaur, Marine, Jean Sévalle, Vincent Lisowski, et al.. (2012). Further characterization of a putative serine protease contributing to the γ-secretase cleavage of β-amyloid precursor protein. Bioorganic & Medicinal Chemistry. 21(4). 1018–1029. 4 indexed citations

15.

Chiche, L., Abdallah Hamzé, André Aumelas, et al.. (2011). Cyclic Peptides with a Diversely Substituted Guanidine Bridge: Solid‐Phase Synthesis and Structural Analysis. Chemistry - A European Journal. 17(9). 2566–2570. 10 indexed citations

16.

Malzert‐Fréon, Aurélie, Sandy Vrignaud, Patrick Saulnier, et al.. (2006). Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent. International Journal of Pharmaceutics. 320(1-2). 157–164. 32 indexed citations

17.

Hamzé, Abdallah, et al.. (2005). Solid phase synthesis of mono- or disubstituted arginine containing peptides from an isothiocitrulline precursor. Tetrahedron Letters. 46(43). 7349–7353. 7 indexed citations

18.

Lisowski, Vincent, et al.. (2005). Design and characterization of a new cell‐permeant inhibitor of the β‐secretase BACE1. British Journal of Pharmacology. 145(2). 228–235. 24 indexed citations

19.

Lisowski, Vincent, Frédéric Fabis, Alain St. Pierre, et al.. (2002). Synthesis of New Aromatic Pyrrolo[2,1- c] [1,4]benzodiazepines and Pyrrolo[1,2- a] thieno[3,2- e] [1,4]diazepines as Anti-tumoral Agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 17(6). 403–407. 19 indexed citations

20.

Lisowski, Vincent, Cécile Enguehard‐Gueiffier, Jean‐Charles Lancelot, et al.. (2001). Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents. Bioorganic & Medicinal Chemistry Letters. 11(16). 2205–2208. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact